Introduction
The Trail Making Test (TMT; Army Individual Test Battery, 1944 ) is one of the most widely used neuropsychological tests in the clinical setting, with Part B of the TMT (TMT-B) the most commonly administered subtest. It is quick and easy to administer and has been shown to be highly sensitive to brain dysfunction in a variety of neurological disorders such as Traumatic Brain Injury and Alzheimer's Disease (e.g. TMT-B is generally regarded as a test of higher-order executive function (Spreen & Strauss, 1998) . Accurate detection of executive impairment is important for the clinical management of many common neurological disorders such as stroke and dementia. A general assumption is that poor performance on TMT-B can be used as a marker for frontal lobe dysfunction. Indeed, the TMT-B is often used clinically for identifying patients with frontal lobe disturbances compared with those with non- Few studies have directly compared performance between patients with frontal and non-frontal lesions. In particular, a seminal study by Stuss and colleagues (2001) found that patients with frontal lobe lesions were slower at completing TMT-B compared with healthy controls and patients with non-frontal brain pathology. Within the frontal lobe patient group, those with dorsolateral damage were most impaired while those with inferior-medial damage were least affected. This is consistent with fMRI findings which show greater activity in the left dorsolateral prefrontal region during TMT-B performance (Moll et al., 2002) . Interestingly also, they noted that in their sample only patients with frontal lobe lesions made more than one error. Stuss and colleagues concluded that the TMT-B is useful for assessing frontal lobe function and in particular that error analysis may be a more informative measure to categorize performance than completion time. However, the sample of frontal patients included over 35% of patients with bilateral lesions as well as traumatic lesions. In contrast, the sample of non-frontal patients did not include bilateral or traumatic lesions, and the sample was relatively small (n=13). These factors may have contributed to the heightened difference in performance found between the two lesion groups.
In contrast, other studies have not found a difference in performance between frontal and non-frontal patients on the TMT-B when comparing completion time data (for a meta-analysis, see Demakis, 2004) . In a study by Reitan and Wolfson (1995) , performance of four patient groups of equal size that differed in lesion location (frontal vs non-frontal) and lateralization (left vs. right) on the TMT-B was compared.
Completion time on the TMT-B was not significantly different for frontal versus nonfrontal patients or between left and right lesioned patients. Similarly, in a relatively large retrospective series of acute stroke patients, no significant difference in performance was observed between frontal and non-frontal stroke patients (Tamez, et al., 2011) . However, neither study investigated error frequency in their analysis or looked at more specific neuroanatomical sub-regions within the frontal lobe (e.g. medial vs. dorsolateral) which Stuss and colleagues proposed as important discriminating factors. In addition, neither study included a healthy control group for comparison.
The aim of our retrospective study was to compare performance on the TMT-B in a large sample of patients with focal frontal and non-frontal lesions, and healthy controls. Importantly, both completion time and error frequency was examined for any differences in performance between groups.
Methods

Participants
Patients assessed in the Neuropsychology Department of the National Hospital for Neurology and Neurosurgery (London, UK) were retrospectively screened for study eligibility. Inclusion criteria for the study were (a) the presence of a single focal lesion confined to the frontal or non-frontal brain region (b) availability of neuropsychological data which must include TMT Part B (c) aged between 18-80 years (d) no gross perceptual disturbances (i.e. above the cut-off on the Incomplete Letters subtest of the VOSP), and (e) absence of psychiatric disorders or previous neurological disorders. A total of 82 patients with focal unilateral lesions who met the inclusion criteria were identified for the study (55 frontal patients, 27 non-frontal patients). All diagnosis was confirmed by clinical neurological investigations including neuroimaging (MRI or CT). All tumour patients had undergone resection prior to neuropsychological assessment. Frontal lesions were reviewed by two independent neurologists from available MRI (n=39; T1 weighted images on 1.5T scanners) and CT scans (n=16). Lesions were then classified by standard laterality (left: n=28, right: n=27) and by a more refined anatomical sub-division of four main subgroups: orbital (n=8), left lateral (n=12), right lateral (n=12) and medial (n=23).
The procedure for classifying lesion location is described in detail elsewhere (Murphy et al., 2013) . In addition, seventy healthy controls who had no prior history of neurological or psychiatric disorders were also included for comparison. The study was approved by the local clinical governance and ethics committees. Some of the data from these patients were gathered as part of a larger study of frontal lobe lesions and have been included in previous published studies (e.g. Robinson, Shallice, Bozzali, & Cipolotti, 2012).
Neuropsychological assessment
As this was a retrospective study, all participants were administered a series of cognitive tests at the time of their neurological investigation. An estimate of premorbid optimal level of functioning was obtained using the National Adult Reading Insert Table 1 here
Statistical analyses
For analyses of completion time data, an Analysis of Covariance (ANCOVA) was employed with group (frontal, non-frontal, healthy control) as the main between subjects factor. Age and NART scores were entered as covariates of no interest in the analyses given that age and intellectual functioning are known to mediate neuropsychological test performance. The raw completion time measure was transformed using a natural log transformation before analyses to deal with the significant skew in the data. Error data were analysed using the Chi-square test.
Where comparisons contained cells of size less than 5, the Fisher's exact test was employed. We divided participants of each group into those who did not make an error and those who made one or more error to assess whether one group is more likely to make an error than another. In view of Stuss et al.'s (2001) finding that only patients with frontal lobe lesions made greater than one error on the TMT, we ran an additional analysis dividing participants into those who made one error and those who made more than one error.
We conducted three main analyses. First, we compared TMT-B performance for each of the two patient groups with the healthy control group separately. This analysis investigated whether TMT-B could distinguish individuals with brain impairment from those without, irrespective of lesion location. Secondly, we compared performance between the two patient groups directly to examine whether performance on the TMT-B is significantly different between them. Finally, we examined possible lateralization or localization effects in performance for patients with frontal lobe lesions.
Results
All groups were well-matched for age, gender and years of education (p>0.1). Table 1 provides a summary of group demographic information. There was no apparent difference between the frontal and non-frontal patient groups in terms of chronicity or side of injury (p>0.1). The time since injury at assessment was also not significantly correlated with TMT-B completion time (p>0.1). On neuropsychological assessment, there was no apparent difference between groups on the NART (p>0.1) or on a test of visual perception (VOSP, Incomplete letters, p>0.1). 
Comparison between frontal/non-frontal patients with healthy controls
Insert Figure 1 here
Comparison between frontal and non-frontal patients
Comparison between the frontal and non-frontal patient group on completion time for the TMT-B revealed no significant difference (F(1,76)=0.39, p=0.53). In addition to conventional null-hypothesis significance testing, we also subjected completion time data to Bayesian analysis which is thought to be able to provide evidence in support of the null-hypothesis (Gallistel, 2009) In regards to errors, there was no significant difference between the frontal and non-frontal groups in the likelihood of making an error and making no errors (χ 2
(1) =1.11, p=0.29). Furthermore, there was also no difference when we compared the likelihood of these two groups in making one or more than one error (p=1.00). In our sample, five patients in the frontal group (8%) and four patients in the non-frontal group (15%) made more than one error.
Comparison between lesion locations for frontal patients
To examine whether lesion location within the frontal lobe had an effect on performance on the TMT-B, frontal patients were divided into separate subgroups based on standard lesion lateralization (left, right) and by more specific neuroanatomical sub-regions (orbital, left lateral, right lateral, medial). We also ran an additional analysis to compare patients with lateral versus medial frontal lesions by combining the patients with left and right lateral lesions into one group. This did not alter the pattern of results.
Discussion
Our findings show that the TMT-B is a reliable test for detecting brain impairment.
Both patients with frontal and non-frontal lobe lesions performed worse than the neurologically intact participants in regards to both efficiency and accuracy. Critically From a clinical perspective, the TMT-B can offer many insights regarding a patient's cognitive abilities. However, our findings suggest it may have limited utility as a tool in detecting executive dysfunction specifically as task performance most likely depends upon a range of cognitive processes, some of which require non-frontal brain regions. As such, caution should be used when drawing conclusions from TMT-B performance alone. Further work is needed to establish whether current findings also extend to the various alternate versions of the task (e.g. Oral or Colour TMT). 
